Vitamin in the crosshairs: targeting pantothenate and coenzyme a biosynthesis for new antituberculosis agents

HS Butman, TJ Kotzé, CS Dowd… - Frontiers in Cellular and …, 2020 - frontiersin.org
Despite decades of dedicated research, there remains a dire need for new drugs against
tuberculosis (TB). Current therapies are generations old and problematic. Resistance to …

Inhibitors of pantothenate synthetase of Mycobacterium tuberculosis–a medicinal chemist perspective

A Suresh, S Srinivasarao, YM Khetmalis, S Nizalapur… - RSC …, 2020 - pubs.rsc.org
Tuberculosis (TB), one of the most prevalent infections, is on the rise today. Although there
are drugs available in the market to combat this lethal disorder, there are several …

Seeking potent anti-tubercular agents: Design, synthesis, anti-tubercular activity and docking study of various ((triazoles/indole)-piperazin-1-yl/1, 4-diazepan-1-yl) …

KM Naidu, S Srinivasarao, N Agnieszka, AK Ewa… - Bioorganic & medicinal …, 2016 - Elsevier
A series of thirty eight novel 3-(4-((substituted-1H-1, 2, 3-triazol-4-yl) methyl) piperazin-1-
yl/1, 4-diazepan-1-yl) benzo [d] isoxazole and 1-(4-(benzo [d] isoxazol-3-yl) piperazin-1-yl/1 …

Design, synthesis and biological evaluation of imidazo [2, 1-b] thiazole and benzo [d] imidazo [2, 1-b] thiazole derivatives as Mycobacterium tuberculosis pantothenate …

G Samala, PB Devi, S Saxena, N Meda… - Bioorganic & medicinal …, 2016 - Elsevier
In the present study, we have designed imidazo [2, 1-b] thiazole and benzo [d] imidazo [2, 1-
b] thiazole derivatives from earlier reported imidazo [1, 2-a] pyridine based Mycobacterium …

Resistance in tuberculosis: what do we know and where can we go?

KD Green, S Garneau-Tsodikova - Frontiers in microbiology, 2013 - frontiersin.org
Tuberculosis (TB) has become a worldwide threat, mainly due to the emergence of multidrug-
resistant (MDR) and extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis …

[HTML][HTML] Potential secondary metabolite from Indonesian Actinobacteria (InaCC A758) against Mycobacterium tuberculosis

MD Rakhmawatie, T Wibawa, P Lisdiyanti… - Iranian Journal of …, 2021 - ncbi.nlm.nih.gov
Objective (s): This study explored Indonesian Actinobacteria which were isolated from
Curcuma zedoaria endophytic microbes and mangrove ecosystem for new …

Development of novel tetrahydrothieno [2, 3-c] pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization …

G Samala, PB Devi, R Nallangi, JP Sridevi… - Bioorganic & medicinal …, 2014 - Elsevier
Abstract Twenty six 2, 6-disubstituted 4, 5, 6, 7-tetrahydrothieno [2, 3-c] pyridine-3-
carboxamide derivatives were designed by molecular hybridization approach using and …

Development of 3-phenyl-4, 5, 6, 7-tetrahydro-1H-pyrazolo [4, 3-c] pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors

G Samala, PB Devi, R Nallangi, P Yogeeswari… - European journal of …, 2013 - Elsevier
Abstract Forty 3-phenyl-4, 5, 6, 7-tetrahydro-1H-pyrazolo [4, 3-c] pyridine derivatives were
synthesized from piperidin-4-one by five step synthesis and evaluated for Mycobacterium …

A high-throughput screen against pantothenate synthetase (PanC) identifies 3-biphenyl-4-cyanopyrrole-2-carboxylic acids as a new class of inhibitor with activity …

A Kumar, A Casey, J Odingo, EA Kesicki, G Abrahams… - PloS one, 2013 - journals.plos.org
The enzyme pantothenate synthetase, PanC, is an attractive drug target in Mycobacterium
tuberculosis. It is essential for the in vitro growth of M. tuberculosis and for survival of the …

Identification and development of pyrazolo [4, 3-c] pyridine carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors

S Amaroju, MN Kalaga, S Srinivasarao… - New Journal of …, 2017 - pubs.rsc.org
The purpose of this study was to prepare various 1-((1-(substituted)-1H-1, 2, 3-triazol-4-yl)
methyl)-N, 3-diphenyl-6, 7-dihydro-1H-pyrazolo [4, 3-c] pyridine-5 (4H)-carboxamides using …